Upgrade

Arcadia Biosciences, Inc.

RKDA

Last
$0.28
Day
+2.2%
1y
-93.3%
5y
-99.7%
52w
-95.2%
SPY YTD
+13.3%
XLP
+7.4%
Earnings
2026-11-0626d
EMA 21
0.35
EMA 50
0.46
EMA 200
1.26
20d high
-59.8%
5y high
-99.7%
5y range
0th
Website · 8 employees · United States

Positions held

Your positions

RKDA isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
-24
Hold
avoid
Signal
Strong Sell
Target
$0.40
Stop
$0.17
Stop distance
39.2%
Target vs last
+43.1%

Fundamentals

Market cap$659,160Enterprise value-$3.52MTrailing P/E—Forward P/E-0.21
PEG—Price / book0.94Beta0.55Dividend yield0.00%
Revenue growth-0.8%Earnings growth—Gross margin34.6%Operating margin-34.4%
Profit margin-2.3%ROE-4.3%ROA-34.8%Debt / equity—
Current ratio3.49Free cash flow-$868,500Analyst recommendationnoneMean target—
52w high$5.7252w low$0.22

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$1.4M$1.1M$0.9M$1.3M$1.5M—
Op margin-34.4%-70.8%-152.6%-108.2%-411.7%—
Net income-$6.3M-$4.4M-$1.3M$0.9M-$4.5M—
Gross margin43.7%36.4%21.3%32.1%43.4%—
Gross profit$0.6M$0.4M$0.2M$0.4M$0.6M—
Operating income-$0.5M-$0.8M-$1.4M-$1.4M-$6.0M—
  • Revenue +31% vs prior quarter ($1.4M vs $1.1M).
  • Gross margin 43.7% (was 36.4% prior quarter).
  • Operating margin expanded to -34.4%.

Yearly (6y)

20252024202320222021
Revenue$4.9M$5.0M$4.5M$7.4M—
Op margin-205.7%-150.9%-135.1%-205.3%—
Net income-$2.3M-$7.0M-$14.0M-$15.4M—
Gross margin36.2%41.3%51.2%17.8%—
Gross profit$1.8M$2.1M$2.3M$1.3M—
Operating income-$10.0M-$7.6M-$6.0M-$15.2M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

RKDA · daily-38.9% over 13 sessions
Close EMA21 EMA50 EMA200
0.200.330.450.580.702026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$6M-$4M-$2M-$0M$1M-412%-184%44%2025-Q22025-Q32025-Q42026-Q12026-Q2